Published in J Biol Chem on April 13, 2011
Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev (2011) 1.67
Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Chem Rev (2011) 1.56
Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability. PLoS One (2012) 0.98
Investigating substrate promiscuity in cyclooxygenase-2: the role of Arg-120 and residues lining the hydrophobic groove. J Biol Chem (2012) 0.97
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. Trends Pharmacol Sci (2014) 0.95
Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer. J Biol Chem (2013) 0.92
The structure of NS-398 bound to cyclooxygenase-2. J Struct Biol (2011) 0.91
Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network. J Biol Chem (2014) 0.86
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide. J Enzyme Inhib Med Chem (2012) 0.85
13-Methylarachidonic acid is a positive allosteric modulator of endocannabinoid oxygenation by cyclooxygenase. J Biol Chem (2015) 0.85
The structure of ibuprofen bound to cyclooxygenase-2. J Struct Biol (2014) 0.85
Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry. Biochemistry (2016) 0.80
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib. Bioorg Med Chem Lett (2013) 0.80
Cyclooxygenase-2 Mediated Oxidation of 2-Arachidonoyl-Lysophospholipids Identifies Unknown Lipid Signaling Pathways. Cell Chem Biol (2016) 0.79
Competition and allostery govern substrate selectivity of cyclooxygenase-2. Proc Natl Acad Sci U S A (2015) 0.79
Prostaglandin H synthase-2-catalyzed oxygenation of 2-arachidonoylglycerol is more sensitive to peroxide tone than oxygenation of arachidonic acid. J Biol Chem (2012) 0.79
Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen. PLoS One (2014) 0.76
Interactions of 2-O-arachidonylglycerol ether and ibuprofen with the allosteric and catalytic subunits of human COX-2. J Lipid Res (2016) 0.76
Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone. J Biol Chem (2016) 0.76
Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit. J Biol Chem (2016) 0.75
Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond. IUBMB Life (2014) 0.75
N-glycosylation site occupancy in human prostaglandin H synthases expressed in Pichia pastoris. Springerplus (2014) 0.75
Crystal structure of rofecoxib bound to human cyclooxygenase-2. Acta Crystallogr F Struct Biol Commun (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr (2005) 61.38
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86
Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr (2001) 21.01
Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc (2008) 16.53
Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr (2006) 14.21
Developments in the CCP4 molecular-graphics project. Acta Crystallogr D Biol Crystallogr (2004) 13.53
Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (2001) 11.23
Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem (2000) 8.86
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem (2000) 2.48
Control of oxygenation in lipoxygenase and cyclooxygenase catalysis. Chem Biol (2007) 2.29
Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem (1997) 2.18
Cyclooxygenases: structural and functional insights. J Lipid Res (2008) 2.14
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem (2002) 2.11
Prostanoids in health and disease. J Lipid Res (2008) 2.06
The productive conformation of arachidonic acid bound to prostaglandin synthase. Science (2000) 1.85
Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature (2000) 1.79
Structural and functional basis of cyclooxygenase inhibition. J Med Chem (2007) 1.75
The COXIB experience: a look in the rearview mirror. Annu Rev Pharmacol Toxicol (2009) 1.74
A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem (2003) 1.69
Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers. J Biol Chem (2009) 1.60
Partnering between monomers of cyclooxygenase-2 homodimers. Proc Natl Acad Sci U S A (2006) 1.49
Prostaglandin endoperoxide H synthase-1: the functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid. J Biol Chem (2000) 1.43
Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem (2010) 1.33
Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J Biol Chem (2001) 1.30
Oxidative metabolism of endocannabinoids by COX-2. Curr Pharm Des (2004) 1.26
Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J Biol Chem (2008) 1.26
Structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1. J Biol Chem (2001) 1.26
The structures of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat (2002) 1.22
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide. Biochemistry (2003) 1.19
The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors. J Biol Chem (1999) 1.15
Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2. Biochem Biophys Res Commun (2002) 1.12
Chemical stability of 2-arachidonylglycerol under biological conditions. Chem Phys Lipids (2002) 1.11
Prostaglandin endoperoxide synthase. The aspirin acetylation region. J Biol Chem (1992) 1.09
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol. J Biol Chem (2001) 1.05
The dynamics of prostaglandin H synthases. Studies with prostaglandin h synthase 2 Y355F unmask mechanisms of time-dependent inhibition and allosteric activation. J Biol Chem (1998) 1.04
Endogenous cannabinoids: structure and metabolism. J Neuroendocrinol (2008) 1.03
Mutational and X-ray crystallographic analysis of the interaction of dihomo-gamma -linolenic acid with prostaglandin endoperoxide H synthases. J Biol Chem (2000) 1.03
The formation of stable fatty acid substrate complexes in prostaglandin H(2) synthase-1. Arch Biochem Biophys (2000) 0.90
Structure of the integral membrane protein CAAX protease Ste24p. Science (2013) 1.38
Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem (2010) 1.33
Structural genomics: from genes to structures with valuable materials and many questions in between. Nat Methods (2008) 1.33
Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer. J Biol Chem (2011) 1.31
Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J (2010) 1.26
The structures of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat (2002) 1.22
Efficient optimization of crystallization conditions by manipulation of drop volume ratio and temperature. Protein Sci (2007) 1.22
Establishing a training set through the visual analysis of crystallization trials. Part I: approximately 150,000 images. Acta Crystallogr D Biol Crystallogr (2008) 1.15
Establishing a training set through the visual analysis of crystallization trials. Part II: crystal examples. Acta Crystallogr D Biol Crystallogr (2008) 1.12
Purification of transmembrane proteins from Saccharomyces cerevisiae for X-ray crystallography. Protein Expr Purif (2010) 1.05
Coordinating the impact of structural genomics on the human α-helical transmembrane proteome. Nat Struct Mol Biol (2013) 1.05
Determination and application of empirically derived detergent phase boundaries to effectively crystallize membrane proteins. Protein Sci (2009) 1.02
Investigating substrate promiscuity in cyclooxygenase-2: the role of Arg-120 and residues lining the hydrophobic groove. J Biol Chem (2012) 0.97
His-311 and Arg-559 are key residues involved in fatty acid oxygenation in pathogen-inducible oxygenase. J Biol Chem (2008) 0.92
The structure of NS-398 bound to cyclooxygenase-2. J Struct Biol (2011) 0.91
Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract. Infect Immun (2013) 0.88
The transition from closed to open conformation of Treponema pallidum outer membrane-associated lipoprotein TP0453 involves membrane sensing and integration by two amphipathic helices. J Biol Chem (2011) 0.86
The crystal structure of α-Dioxygenase provides insight into diversity in the cyclooxygenase-peroxidase superfamily. Biochemistry (2013) 0.80
Crystal structures of α-dioxygenase from Oryza sativa: insights into substrate binding and activation by hydrogen peroxide. Protein Sci (2013) 0.77